Green tea: cancer preventive beverage and/or drug
- 22 October 2002
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 188 (1-2) , 9-13
- https://doi.org/10.1016/s0304-3835(02)00379-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
- Phase I Trial of Oral Green Tea Extract in Adult Patients With Solid TumorsJournal of Clinical Oncology, 2001
- Green Tea and the Risk of Gastric Cancer in JapanNew England Journal of Medicine, 2001
- Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting preventionBioFactors, 2000
- Two stages of cancer prevention with green teaZeitschrift für Krebsforschung und Klinische Onkologie, 1999
- Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissueCarcinogenesis: Integrative Cancer Research, 1998
- Cancer-Preventive Effects of Drinking Green Tea among a Japanese PopulationPreventive Medicine, 1997
- Reduced Risk of Esophageal Cancer Associated With Green Tea ConsumptionJNCI Journal of the National Cancer Institute, 1994
- A Case‐Control Study of Gastric Cancer and Diet in Northern Kyushu, JapanJapanese Journal of Cancer Research, 1988
- Antitumor promoting activity of (−)‐epigallocatechin gallate, the main constituent of “Tannin” in green teaPhytotherapy Research, 1987